Curon Medical Inc.

For medical device start-ups, the hurdles to bringing a new device to market seem higher than ever given the current financial constraints, regulatory challenges, and increasing demand for data that d

by Diana Tucker At the 12th World Congress of Endoscopic Surgery, hosted recently in Washington, DC, by the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES), physicians discussed t

Novasys hopes that its rigorous and costly clinical trials strategy, which slowed FDA clearance of its incontinence device, will pay off by providing reimbursement that will drive adoption. by Stephen

EGS's novel endoluminal approach to GERD surgery could introduce a revolution in clinical practice, changing not just how GERD surgery is done, but who does it as well. By David Cassak Stefan Kraemer,